AI assistant
IMMUNIC, INC. — Director's Dealing 2019
Dec 4, 2019
10196_dirs_2019-12-04_fd1dcb85-deb9-41fa-9931-b9ec11c6cb61.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: IMMUNIC, INC. (IMUX)
CIK: 0001280776
Period of Report: 2019-12-02
Reporting Person: Nash Duane (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2019-12-02 | Common Stock | M | 22157 | — | Acquired | 22362 | Direct |
| 2019-12-03 | Common Stock | F | 7930 | $7.1541 | Disposed | 14432 | Direct |
| 2019-12-04 | Common Stock | S | 4400 | $6.96 | Disposed | 10032 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2019-12-02 | Restricted Stock Units | $ | M | 22157 | Disposed | Common Stock (22157) | Direct |
Footnotes
F1: Restricted stock units ("RSUs") convert into common stock on a one-for-one basis.
F2: Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the settlement of RSUs granted to the Reporting Person.
F3: The price reported in Column 4 is an average price. These shares were sold in multiple transactions at prices ranging from $7.1508 and $7.1572 per share.
F4: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
F5: On January 11, 2019, the Reporting Person was granted 886,316 restricted stock units as consideration of cancelled stock options. Pursuant to the Reporting Person's amended RSU Agreement, RSUs that vested prior to April 22, 2019 were settled on December 2, 2019.